1 83850sek
-1,2 %
Date:2026-11-06Time:18:00:00Latest report:Q3-2026List:Large CapTicker:AZN
Market Cap:2 851 633 msekEnterprise Value:3 110 270 msekNet Sales:62 384 musdEarnings:11 030 musdEmployees:0ISIN:GB0009895292

Ratios

10-year key figure history for AstraZeneca turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AstraZeneca with index and moving average MA50 and MA200.

Stockprice:1 838,50
MA50:1 641,54
MA200:1 706,27
Price/MA200:7,7 %
RSI (14):71,3
Price/MA50:12,0 %

Description

AstraZeneca is a global pharmaceutical company focused on the research, development and marketing of prescription medicines, primarily for the treatment of diseases in the therapeutic areas of respiratory, cardiovascular/metabolic and cancer. In addition to its core business, the company also has a focus on the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in all global regions and is headquartered in Cambridge, UK.